These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16618752)
1. Down-regulation of CXCL5 inhibits squamous carcinogenesis. Miyazaki H; Patel V; Wang H; Edmunds RK; Gutkind JS; Yeudall WA Cancer Res; 2006 Apr; 66(8):4279-84. PubMed ID: 16618752 [TBL] [Abstract][Full Text] [Related]
2. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915 [TBL] [Abstract][Full Text] [Related]
3. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732 [TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration. Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072 [TBL] [Abstract][Full Text] [Related]
5. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma. Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071 [TBL] [Abstract][Full Text] [Related]
6. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580 [TBL] [Abstract][Full Text] [Related]
8. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157 [TBL] [Abstract][Full Text] [Related]
9. VEGF-C contributes to head and neck squamous cell carcinoma growth and motility. Benke EM; Ji Y; Patel V; Wang H; Miyazaki H; Yeudall WA Oral Oncol; 2010 Apr; 46(4):e19-24. PubMed ID: 20227330 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma. Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Bock JM; Sinclair LL; Bedford NS; Jackson RE; Lee JH; Trask DK Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):355-62. PubMed ID: 18427000 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673 [TBL] [Abstract][Full Text] [Related]
13. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250 [TBL] [Abstract][Full Text] [Related]
14. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Wang B; Hendricks DT; Wamunyokoli F; Parker MI Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656 [TBL] [Abstract][Full Text] [Related]
15. Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma. Li DJ; Deng G; Xiao ZQ; Yao HX; Li C; Peng F; Li MY; Zhang PF; Chen YH; Chen ZC Cancer Lett; 2009 Jun; 279(1):65-73. PubMed ID: 19231067 [TBL] [Abstract][Full Text] [Related]
16. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion. Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718 [TBL] [Abstract][Full Text] [Related]
17. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Wang SJ; Wreesmann VB; Bourguignon LY Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of S100A2 in lymph node metastases of head and neck cancer. Zhang X; Hunt JL; Shin DM; Chen ZG Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307 [TBL] [Abstract][Full Text] [Related]
19. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Barbieri CE; Tang LJ; Brown KA; Pietenpol JA Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358 [TBL] [Abstract][Full Text] [Related]
20. CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H Cancer Res; 2007 Aug; 67(15):7518-24. PubMed ID: 17671223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]